BMY Bristol-Myers Squibb
Stock · NYSE · United States · Healthcare · US1101221083
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Bristol-Myers Squibb, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
62.67 USD
-0.74%
52-week range
45.27 – 68.64
Dividend yield3.99%
Market cap129.0B
NowoTrade score
70 Grade A
Price history
Daily prices in USD.
Updated 06 Nov 2026 17:29. Information, not advice.
Results
Next results
04 Feb 2027
in 90 days · 08:00 · estimate 1.50
Last results
1.35 vs 1.17 estimated
29 Oct 2026 · Beat +15.2%
Beat the estimate
11 of 12
0 missed · 1 in line · 10 beats in a row
Average surprise
+15.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 08:00 | 1.50 | — | — | Upcoming |
| 29 Oct 2026 07:00 | 1.17 | 1.35 | +15.2% | Beat |
| 30 Jul 2026 07:00 | 1.60 | 2.04 | +27.7% | Beat |
| 30 Apr 2026 07:00 | 1.42 | 1.58 | +11.2% | Beat |
| 05 Feb 2026 07:00 | 1.20 | 1.26 | +4.6% | Beat |
| 30 Oct 2025 07:00 | 1.52 | 1.63 | +7.6% | Beat |
| 31 Jul 2025 07:00 | 1.10 | 1.46 | +32.6% | Beat |
| 24 Apr 2025 07:00 | 1.50 | 1.80 | +19.9% | Beat |
| 06 Feb 2025 06:00 | 1.47 | 1.67 | +13.8% | Beat |
| 31 Oct 2024 06:00 | 1.50 | 1.80 | +20.0% | Beat |
| 26 Jul 2024 06:00 | 1.63 | 2.07 | +27.4% | Beat |
| 25 Apr 2024 06:00 | -4.40 | -4.40 | -0.1% | In line |
| 02 Feb 2024 06:00 | 1.58 | 1.70 | +7.8% | Beat |
| 26 Oct 2023 06:00 | 1.77 | 2.00 | +13.0% | Beat |
| 27 Jul 2023 07:00 | 1.99 | 1.75 | -12.0% | Miss |
| 27 Apr 2023 06:00 | 1.97 | 2.05 | +3.9% | Beat |
| 02 Feb 2023 06:00 | 1.73 | 1.82 | +5.2% | Beat |
| 25 Oct 2022 19:00 | 1.83 | 1.99 | +8.5% | Beat |
| 27 Jul 2022 06:00 | 1.80 | 1.93 | +7.3% | Beat |
| 29 Apr 2022 06:00 | 1.90 | 1.96 | +3.3% | Beat |
| 04 Feb 2022 06:00 | 1.80 | 1.83 | +1.7% | Beat |
| 27 Oct 2021 06:00 | 1.92 | 2.00 | +4.3% | Beat |
| 28 Jul 2021 06:00 | 1.90 | 1.93 | +1.8% | Beat |
| 29 Apr 2021 06:00 | 1.81 | 1.74 | -3.9% | Miss |
| 04 Feb 2021 06:00 | 1.42 | 1.46 | +3.1% | Beat |
Annual results
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 48.2B | -0.2% | 7.1B | 14.6% | 3.46 | +178.5% | 12.8B |
| 2024 | 48.3B | +7.3% | -8.9B | -18.5% | -4.41 | -214.2% | 13.9B |
| 2023 | 45B | -2.5% | 8B | 17.8% | 3.86 | +30.8% | 12.7B |
| 2022 | 46.2B | — | 6.3B | 13.7% | 2.95 | — | 11.9B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 04 Apr 2025 | 56.82 | 57.17 | 54.72 | 55.30 | -4.36% | 14,657,900 | 0.6200 |
| 03 Apr 2025 | 60.60 | 60.80 | 57.66 | 57.82 | -2.99% | 13,246,900 | |
| 02 Apr 2025 | 59.81 | 60.24 | 59.16 | 59.60 | +0.08% | 8,310,000 | |
| 01 Apr 2025 | 60.77 | 61.10 | 59.24 | 59.55 | -2.36% | 9,623,800 | |
| 31 Mar 2025 | 59.80 | 61.64 | 59.37 | 60.99 | +1.62% | 11,615,900 | |
| 28 Mar 2025 | 59.40 | 60.11 | 58.23 | 60.02 | +1.90% | 10,791,600 | |
| 27 Mar 2025 | 59.18 | 59.56 | 58.77 | 58.90 | -0.52% | 8,751,200 | |
| 26 Mar 2025 | 59.32 | 59.69 | 58.53 | 59.21 | +0.03% | 11,579,500 | |
| 25 Mar 2025 | 61.21 | 61.49 | 59.18 | 59.19 | -3.05% | 10,969,100 | |
| 24 Mar 2025 | 60.79 | 61.25 | 59.97 | 61.05 | -0.03% | 11,976,800 | |
| 21 Mar 2025 | 60.23 | 61.34 | 59.84 | 61.07 | +1.08% | 25,865,100 | |
| 20 Mar 2025 | 59.86 | 61.07 | 59.78 | 60.42 | +0.57% | 12,197,400 | |
| 19 Mar 2025 | 59.86 | 60.55 | 59.46 | 60.08 | +0.30% | 8,304,200 | |
| 18 Mar 2025 | 59.88 | 60.26 | 59.54 | 59.90 | -0.15% | 9,967,900 | |
| 17 Mar 2025 | 59.16 | 60.13 | 58.36 | 59.99 | +1.66% | 9,666,800 | |
| 14 Mar 2025 | 59.84 | 59.99 | 58.72 | 59.01 | -2.11% | 11,905,700 | |
| 13 Mar 2025 | 59.99 | 60.76 | 59.79 | 60.28 | +0.79% | 8,990,400 | |
| 12 Mar 2025 | 60.72 | 60.82 | 59.52 | 59.81 | -2.76% | 10,812,400 | |
| 11 Mar 2025 | 62.80 | 63.33 | 61.23 | 61.51 | -2.54% | 14,637,900 | |
| 10 Mar 2025 | 60.95 | 63.16 | 60.72 | 63.11 | +3.31% | 20,295,700 | |
| 07 Mar 2025 | 60.45 | 63.11 | 60.27 | 61.09 | +1.51% | 18,538,200 | |
| 06 Mar 2025 | 59.94 | 60.70 | 59.03 | 60.18 | +0.60% | 10,682,400 | |
| 05 Mar 2025 | 59.43 | 60.26 | 59.38 | 59.82 | +0.64% | 9,707,000 | |
| 04 Mar 2025 | 59.96 | 60.69 | 59.29 | 59.44 | -0.72% | 16,502,200 | |
| 03 Mar 2025 | 59.75 | 59.92 | 59.01 | 59.87 | +0.42% | 11,214,100 |
Page 17 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
Key data
- Previous close
- 63.13 USD
- Market cap
- 129.0B
- Dividend yield
- 3.99%
- 5-year average yield
- 3.86%
- Payout ratio
- 56%
- Last dividend
- 0.6300 USD · 02 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 02 Oct 2026 | 0.6300 USD |
| 02 Jul 2026 | 0.6300 USD |
| 02 Apr 2026 | 0.6300 USD |
| 02 Jan 2026 | 0.6300 USD |
| 03 Oct 2025 | 0.6200 USD |
| 03 Jul 2025 | 0.6200 USD |
| 04 Apr 2025 | 0.6200 USD |
| 03 Jan 2025 | 0.6200 USD |
| 04 Oct 2024 | 0.6000 USD |
| 05 Jul 2024 | 0.6000 USD |
| 04 Apr 2024 | 0.6000 USD |
| 04 Jan 2024 | 0.6000 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 16.6 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 23.1 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 7.4 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 10.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 9.1 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 2.3 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 14.07× | Good | 32.71× |
| P/E (forward) | 9.54× | Good | 15.76× |
| Price / book | 5.54× | Weak | 3.74× |
| Price / sales | 2.59× | Fair | 3.52× |
| EV / EBITDA | 8.96× | Good | 13.54× |
| Free cash flow yield | 4.9% | Fair | 3% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 70.5% | Good | 66.1% |
| Operating margin | 33.8% | Good | 8% |
| Net margin | 18.5% | Good | 3.5% |
| Return on equity | 44% | Good | 6.4% |
| Return on assets | 10.9% | Good | 3.9% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 1.4% | Weak | 10.5% |
| EPS growth / year | 5.5% | Fair | 7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.91× | Weak | 0.52× |
| Net debt / EBITDA | 1.77× | Fair | 1.62× |
| Interest cover | 7.26× | Fair | 3.3× |
| Current ratio | 1.59× | Good | 2.12× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 55.9% | Fair | 0% |
| Payout of free cash flow | 79.3% | Weak | 45% |
| Payout of free cash flow (3 years) | 37.2% | Good | — |
| Dividend growth / year | 4.7% | Fair | 7.1% |
| Years of rising dividends | 4 | Fair | 4.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow BMY and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.